Infusion site infection in a patient using U-500 insulin delivered via insulin pump

Practical Diabetes International

Volumn 24, Issue 9, 2007, Pages 489-

  Hundia, Vikram ^a   Pettit, Andrew ^a   Egerton, June ^a  

^a AIREDALE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GLICLAZIDE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ROSIGLITAZONE;

ABSCESS DRAINAGE; ADULT; ARTICLE; CASE REPORT; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; GLYCEMIC CONTROL; HUMAN; INJECTION SITE ABSCESS; INJECTION SITE INFECTION; INSULIN INFUSION; INSULIN PUMP; INSULIN RESISTANCE; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; SURGICAL TECHNIQUE;

EID: 38049073197     PISSN: 13578170     EISSN: 1528252X     Source Type: Journal    
DOI: 10.1002/pdi.1184     Document Type: Article

References (3)

1. Diabetes Control and Complications Trial Research Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 1995; 18: 361-376.
2. Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 2001; 161: 2293-2300.
3. Mecklenburg IRS, Guinn TS. Complications of insulin pump therapy: the effect of insulin preparation. Diabetes Care 1985; 8:367-370.